BioWorld Asia

March 15, 2006

Running The Business’ Now Again Focus For SkyePharma

LONDON - SkyePharma plc rebuffed activist shareholders at an extraordinary general meeting (EGM) last week, with 53 percent of shareholders voting against rebel demands to appoint their man, Bob Thian, as chairman. (BioWorld International) Read More

Aresa Raises DKK54M To Fund Trials Of Mine-Detecting Plants

Study Pinpoints Hypertension Role For Blood Vessel Protein

Industry Demanding Right To Choose Regarding GM Crops

Acambis Outlines Defense For Bavarian Nordic’s MVA Claims

Egalet Gets $27.6M For Trials Of Controlled-Release Drugs

BioBank Officially Starts Gathering Genetic Data

Once Profitable, Flamel Now Losing Money: $27M In 2005

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...